This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07697/identifier/pubchem-substance/
n5http://linked.opendata.cz/resource/drugbank/drug/DB07697/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB07697/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07697/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07697/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07697
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n10:DB07697 n12:DB07697
dcterms:title
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine
adms:identifier
n4:99444168 n5:DB07697 n6:DZG n11:565056 n14:650361
n7:IUPAC-Name
n8:271B5DB8-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B5DBE-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B5DBD-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B5DBA-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B5DBB-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B5DBC-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B5DB6-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B5DB7-363D-11E5-9242-09173F13E4C5 n8:271B5DB4-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B5DB5-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B5DC4-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B5DC5-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B5DBF-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B5DC0-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B5DC2-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B5DC1-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B5DC3-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B5DC9-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B5DCB-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B5DCC-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B5DC8-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B5DC7-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B5DCA-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B5DB9-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B5DC6-363D-11E5-9242-09173F13E4C5